We propose to investigate the interactive effects of substance abuse and rurality on the clinical outcomes of schizophrenia in a prospective longitudinal study. No study has yet examined the clinical outcomes associated with substance abuse in rural areas, despite the fact that substance abuse is the most prevalent comorbid condition associated with schizophrenia. Further, rural areas lack specialized mental health care services to deal with such specialized needs. Currently, gaps in our knowledge prevent us from being able to target problem areas for these patients and to develop effective and accessible services for this population. Consequently, the proposed study will address these gaps by answering two questions: What are the clinical outcomes of patients with schizophrenia and comorbid substance abuse in rural areas? and What patient and mental health service factors account for urban and rural differences in clinical outcomes for patients with substance abuse and schizophrenia? The study design involves following 192 patients for eighteen months after an index hospitalization. Patients from one urban and three quite different rural areas will be assessed on multiple domains through clinical interviews as well as through family and mental health professional informants.
The aim of data analysis will be to understand the unique outcomes of substance abuse in rural areas for patients with schizophrenia. We will employ regression techniques to examine the interactive effects of rurality and substance abuse controlling for patient and mental health service access and utilization factors. Results will guide treatment efforts in rural areas by giving information about what clinical outcomes are most affected by substance abuse and pointing to patient, services, and community factors that are related to these outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Research Grants (R03)
Project #
1R03MH049123-01A1
Application #
2248672
Study Section
Services Research Review Committee (SER)
Project Start
1992-09-15
Project End
1994-08-31
Budget Start
1992-09-15
Budget End
1993-08-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Fischer, Ellen P; McSweeney, Jean C; Pyne, Jeffrey M et al. (2008) Influence of family involvement and substance use on sustained utilization of services for schizophrenia. Psychiatr Serv 59:902-8
Owen, Richard R; Fischer, Ellen P; Kirchner, JoAnn E et al. (2003) Clinical practice variations in prescribing antipsychotics for patients with schizophrenia. Am J Med Qual 18:140-6
Owen, Richard R; Thrush, Carol R; Hudson, Teresa J et al. (2002) Using an explicit guideline-based criterion and implicit review to assess antipsychotic dosing performance for schizophrenia. Int J Qual Health Care 14:199-206
Owen, R R; Thrush, C R; Kirchner, J E et al. (2000) Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care 12:475-82
Fischer, E P; Owen, R R (1999) Quality of public sector care for schizophrenia in Arkansas. Ment Health Serv Res 1:213-21
Hudson, T J; Owen, R R; Lancaster, A E et al. (1999) The feasibility of using automated data to assess guideline-concordant care for schizophrenia. J Med Syst 23:299-307
Cuffel, B J; Fischer, E P; Owen Jr, R R et al. (1997) An instrument for measurement of outcomes of care for schizophrenia. Issues in development and implementation. Eval Health Prof 20:96-108
Fischer, E P; Owen Jr, R R; Cuffel, B J (1996) Substance abuse, community service use, and symptom severity of urban and rural residents with schizoprhenia. Psychiatr Serv 47:980-4
Cuffel, B J; Alford, J; Fischer, E P et al. (1996) Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis 184:653-9
Owen, R R; Fischer, E P; Booth, B M et al. (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 47:853-8